Navigation Links
Talecris Biotherapeutics Announces First Quarter 2011 Results
Date:4/27/2011

7)(4,590)Other(60)(2)Changes in assets and liabilities:Accounts receivable(17,022)(31,252)Inventories(8,821)(3,136)Prepaid expenses and other assets11,3407,814Accounts payable(11,543)(12,386)Accrued expenses and other liabilities(21,552)(3,734)Interest payable11,62411,625Net cash provided by operating activities39,63430,670Cash flows from investing activities:Purchase of property, plant, and equipment(53,266)(17,690)Other190174Net cash used in investing activities(53,076)(17,516)Cash flows from financing activities:Borrowings under revolving credit facility302212Repayments of borrowings under revolving credit facility(302)(212)Financing transaction costs-(78)Repayments of capital lease obligations(205)(176)Proceeds from exercises of stock options1,3142,937Repurchases of common stock (2,199)(4,917)Excess tax benefits from share-based payment arrangements1,0774,590Net cash (used in) provided by financing activities(13)2,356Effect of exchange rate changes on cash and cash equivalents917(484)Net (decrease) increase in cash and cash equivalents(12,538)15,026Cash and cash equivalents at beginning of period197,87665,239Cash and cash equivalents at end of period$
85,338$
80,265EXHIBIT A:  MATTERS AFFECTING COMPARABILITYTalecris believes that the comparability of the financial results between the periods presented is significantly impacted by the following items:

Definitive Merger Agreement with Grifols The company incurred legal, accounting, and other fees of approximately $1.1 million associated with the definitive merger agreement with Grifols for which no amounts were incurred during the comparable prior year period.  The company is obligated to pay additional fees totaling $21.3 million to investment bankers upon successful closing of the merger transaction.  

Under the terms of the definitive merger agreement with Grifols, Talecris is permitted to offer retention amounts up to $15.0 million to employees.  As of March 31
'/>"/>

SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
2. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
3. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
4. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
5. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
6. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
7. Talecris Added to NASDAQ Biotechnology Index
8. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
9. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
10. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
11. Talecris Biotherapeutics Announces Premerger HSR Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Knowledgent , the data and analytics ... advanced analytics utilizing data lakes in the healthcare industry. , As the Internet of ... of data over the last few years as more entities become technology enabled through ...
(Date:9/1/2015)... ... 2015 , ... Industry leader iLab Solutions recently announced Gerard ... position, Gibbs will lead iLab’s business operations in the region, with an emphasis ... not only introducing iLab to potential partners but support and management of accounts ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... and colleagues from University of California Los Angeles, Boston University School of Medicine, ... Prevention appears in PLOS One, the world’s first multidisciplinary Open Access journal. ...
(Date:9/1/2015)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces ... of Directors as a Non-Executive Director. Sara will also be ... the Shire Board. Both appointments will be effective as of ... President and Chief Executive Officer of Dun & Bradstreet, Inc. ... D&B, she helped drive the transformation of the company from ...
Breaking Biology Technology:New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Shire Appoints Sara Mathew to Board of Directors 2
... Mich., Nov. 20 GeneGo, Inc., the ... systems biology, announced,today that Utrecht University will ... for drug innovation. MetaDrug is designed for ... off-target effects for,new compounds structures. Its content ...
... TORONTO, Nov. 20 /PRNewswire-FirstCall/ - ARIUS Research ... developing the next wave of,antibody therapeutics, today ... of Research, will present at the 14th ... Pereira will present on,ARIUS, non-traditional approach to ...
... Beckman Coulter,Inc. (NYSE: BEC ), a ... automate, and innovate complex biomedical testing,announced today that ... present at the Lazard Capital Markets Fourth Annual,Healthcare ... p.m. (ET). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) ...
Cached Biology Technology:Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation 2ARIUS to present at BioNorth Biotechnology and Life Sciences Conference 2Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
(Date:8/5/2015)... According to a new market research report, ... (BFSI, Airport, IT & Telecom, Utilities, Education, Defense & ... published by MarketsandMarkets, defines and segments the Physical Identity ... global PIAM Market is estimated to grow from $272.2 ... a CAGR of 14.9 % from 2014 to 2019. ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... More than 2,000 years after Archimedes found a way to ... mass in two different fluids, MIT scientists have used the ... to measure the density of a single cell. "Density ... Grover, a research associate in MIT,s Department of Biological Engineering. ...
... 21, 2011) -- The U.S. Department of Defense (DOD) ... of Engineering researchers for high-tech, specialized measuring equipment that ... engineering applications. The University of Arizona captured five of ... Engineering awardees are Armin Sorooshian of the Department of ...
... Richmond, Va. (June 20, 2011) Researchers at ... mechanisms in mitochondria that have implications for cancer as ... disease, heart disease and hypertension. This discovery has pioneered ... research ripe with possibilities of developing future gene therapies ...
Cached Biology News:How dense is a cell? 2How dense is a cell? 3UA engineering college lands national support for equipment used in unique research 2Discoveries in mitochondria open new field of cancer research 2
... sets a new standard for high performance ... new design in instrumentation, this easy-to-use benchtop ... The BD FACSAria instrument is the first ... flow cell. This new flow cell ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Biology Products: